Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
January 28, 2020
Dual Monoclonal Antibody Therapy in Patients With Systemic AL Amyloidosis and Cardiac Involvement
Amandeep Godara, Nauman Saleem Siddiqui, Lisa X Lee, et al.
Kidney International Reports
|
September 18, 2024
Gene Expression Sets and Renal Profiling from the Renal AL Amyloid Involvement and NEOD00 (RAIN) Trial
Cindy Varga, Felix Eichinger, Viji Nair, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 5, 2025
Plasma Proteomic Profiles Among White and African American Individuals With Monoclonal Gammopathy of Unknown Significance (MGUS) and Multiple Myeloma (MM)
Cindy Varga, Kip D Zimmerman, David M Foureau, et al.
Life (Basel, Switzerland)
|
March 28, 2024
Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study)
Hamid Ehsan, Myra Robinson, Peter M Voorhees, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 16, 2023
Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study)
Hamid Ehsan, Alec Britt, Peter M Voorhees, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 10, 2017
Primary Amyloidosis With Renal Involvement: Outcomes in 77 Consecutive Patients at a Single Center
Sandy W Wong, Denis Toskic, Melissa Warner, et al.
British Journal of Cancer Research
|
January 10, 2025
Seeking Amyloidosis Very Early: Free light Chain Differentials and IGLV Gene Use as Screening Variables for Light-chain Amyloidosis in λ Monoclonal Gammopathies
Ping Zhou, Mahesh M Mansukhani, Raymond Yeh, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 28, 2022
Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma
David M Foureau, Barry A Paul, Fei Guo, et al.
Experimental Hematology & Oncology
|
October 26, 2018
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth
Xun Ma, Sandy W Wong, Ping Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 8, 2025
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 Institutes
Cindy Varga, Myra Robinson, Vikas Gupta, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Clinical Lymphoma, Myeloma & Leukemia
|
January 28, 2020
Dual Monoclonal Antibody Therapy in Patients With Systemic AL Amyloidosis and Cardiac Involvement
Amandeep Godara, Nauman Saleem Siddiqui, Lisa X Lee, et al.
Kidney International Reports
|
September 18, 2024
Gene Expression Sets and Renal Profiling from the Renal AL Amyloid Involvement and NEOD00 (RAIN) Trial
Cindy Varga, Felix Eichinger, Viji Nair, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 5, 2025
Plasma Proteomic Profiles Among White and African American Individuals With Monoclonal Gammopathy of Unknown Significance (MGUS) and Multiple Myeloma (MM)
Cindy Varga, Kip D Zimmerman, David M Foureau, et al.
Life (Basel, Switzerland)
|
March 28, 2024
Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study)
Hamid Ehsan, Myra Robinson, Peter M Voorhees, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 16, 2023
Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study)
Hamid Ehsan, Alec Britt, Peter M Voorhees, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 10, 2017
Primary Amyloidosis With Renal Involvement: Outcomes in 77 Consecutive Patients at a Single Center
Sandy W Wong, Denis Toskic, Melissa Warner, et al.
British Journal of Cancer Research
|
January 10, 2025
Seeking Amyloidosis Very Early: Free light Chain Differentials and IGLV Gene Use as Screening Variables for Light-chain Amyloidosis in λ Monoclonal Gammopathies
Ping Zhou, Mahesh M Mansukhani, Raymond Yeh, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 28, 2022
Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma
David M Foureau, Barry A Paul, Fei Guo, et al.
Experimental Hematology & Oncology
|
October 26, 2018
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth
Xun Ma, Sandy W Wong, Ping Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 8, 2025
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 Institutes
Cindy Varga, Myra Robinson, Vikas Gupta, et al.
Page
of 5